Chiasma (CHMA) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.

CHMA Stock Analysis Overview . What this means: InvestorsObserver gives Chiasma Inc (CHMA) an overall rank of 44, which is below average. Chiasma Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Chiasma Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CHMA stock price. Find the latest analyst research for Chiasma, Inc. Common Stock (CHMA) at Nasdaq.com. Jul 01, 2020 · One stock that might be an intriguing choice for investors right now is Chiasma, Inc. CHMA. This is because this security in the Medical - Biomedical and Genetics space is seeing solid earnings Earnings Chiasma (NASDAQ:CHMA) Earnings Information. Chiasma last released its quarterly earnings results on May 7th, 2020. The biotechnology company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.31) by $0.05.

Jul 17, 2020 · CHMA amount got a boost by 15.92% or $0.66 versus $4.11 at the end of the prior session. This change led market cap to move at 270.84M, putting the price 65.62% below the 52-week high and -48.43% above the 52-week low. The company’s stock has a normal trading capacity of 1.3 million shares while the relative volume is 1.81.

Chiasma (CHMA) Stock Plummets on Disappointing FDA Letter. By Rachel Graf. Apr 18, 2016 1:12 PM EDT. INVESTING. Chiasma plunges after FDA rejects application for growth disorder drug. Jul 20, 2020 · Chiasma, Inc. (CHMA), a commercial biopharmaceutical company focused on developing and commercializing oral therapies utilizing its proprietary Transient Permeability Enhancer delivery platform technology to reduce the burden of chronic injections for people with rare diseases, today announced the pricing of its previously announced underwritten public offering of 12,500,000 shares of its common stock As CHMA breaks its upward wedge pattern, a short position is entered with a tight stop. Factors leading to the decision: Huge rejection at the ATH, creating a new major down-trend Lower trendline of an upward wedge has been broken Heavier bearish volume showed up at prior dip, getting the attention of short sellers Price came back up and re-tested the CHMA Stock Price Chart Technical Analysis Charts. CHMA Price/Volume Stats. Current price $4.67 : 52-week high $9.25 : Prev. close $4.65 : 52-week low $2.88 : Day low

Real time Chiasma (CHMA) stock price quote, stock graph, news & analysis.

CHMA Stock Price Chart Technical Analysis Charts. CHMA Price/Volume Stats. Current price $4.67 : 52-week high $9.25 : Prev. close $4.65 : 52-week low $2.88 : Day low CHMA, Chiasma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Chiasma Inc. (NASDAQ: CHMA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. CHMA stock quote, chart and news. Get Chiasma, Inc.'s stock price today.